Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What is an antibiotic?

P S Lietman

    The Journal of Pediatrics
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Antibiotic effectiveness relies on targeting bacterial cells selectively, impacting cell walls, proteins, or nucleic acids. Understanding drug delivery and biochemical actions is key to maximizing efficacy and minimizing adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production.

    Human & experimental toxicology·2004
    Same author

    Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

    Antimicrobial agents and chemotherapy·2001
    Same author

    Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

    Antimicrobial agents and chemotherapy·1999
    Same author

    The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet.

    Antiviral research·1998
    Same author

    Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.

    Antimicrobial agents and chemotherapy·1998
    Same author

    Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.

    AIDS (London, England)·1998
    Same journal

    Respiratory Syncytial Virus Immunization Disparities in Mothers and Infants at the Birth Hospitalization: A Cross-Sectional Study.

    The Journal of pediatrics·2026
    Same journal

    Blood-Based Biomarkers Predict Cerebral Palsy and Cognitive Delay in Hypoxic-Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Controlled Trial.

    The Journal of pediatrics·2026
    Same journal

    Does Mild Head Injury in Childhood Affect Later School Performance? A Sibling Comparison Cohort Study.

    The Journal of pediatrics·2026
    Same journal

    Risk Factors for Mortality and Age at Discharge in Preterm Infants with Congenital Heart Disease.

    The Journal of pediatrics·2026
    Same journal

    To Cool or Not to Cool in Low- and Middle-Income Countries:? A Call for Resources, Training and Shared Knowledge.

    The Journal of pediatrics·2026
    Same journal

    Responsible Research Practices in Pediatrics: How Reporting Guidelines Can Be Used to Improve Trial Design and Conduct.

    The Journal of pediatrics·2026
    See all related articles

    Area of Science:

    • Microbiology
    • Pharmacology
    • Toxicology

    Background:

    • Selective toxicity of antibiotics is crucial for targeting bacterial cells while sparing host cells.
    • Antibiotics exert effects by inhibiting essential bacterial processes like cell wall synthesis, protein production, and nucleic acid or folic acid metabolism.

    Purpose of the Study:

    • To explore the diverse sites of antibiotic action and their role in selective toxicity.
    • To examine the influence of drug delivery and pharmacokinetic properties on antibiotic efficacy and resistance.
    • To elucidate the mechanisms underlying antibiotic-induced adverse effects, distinguishing between immunologic and non-immunologic responses.

    Main Methods:

    • Review of existing literature on antibiotic mechanisms of action.
    • Analysis of pharmacokinetic factors influencing drug concentration at the site of action.

    Related Experiment Videos

  • Examination of biochemical pathways involved in antibiotic adverse effects.

    • Main Results:

    • Antibiotic efficacy and resistance are intrinsically linked to their specific sites of action and the ability to reach these sites in sufficient concentrations.
    • Bacterial transport mechanisms and human pharmacokinetic attributes significantly impact antibiotic performance.
    • Non-immunologic adverse effects are typically linked to unintended biochemical interactions rather than a failure of selective toxicity.

    Conclusions:

    • Understanding the biochemical basis of antibiotic action and transport is essential for developing safer and more effective antimicrobial therapies.
    • Minimizing undesired side effects requires a comprehensive understanding of drug interactions and biochemical pathways.
    • Future drug development should focus on optimizing selective toxicity and pharmacokinetic profiles to enhance therapeutic outcomes.